The funding will be used to expand reach, enhance branding as well as improve technology stack
Fitterfly, a healthtech start-up working in the field of digital health and therapeutics has announced that it has raised $12 million in Series A funding led by Amazon Smbhav Venture Fund and Fireside Ventures. The co-investors in this round include 9 Unicorns, Venture Catalysts and Nihar Parikh, Founder of 4point0 Health Ventures and Sriram Natarajan, Founder of Molbio.
The funding will be used to increase the reach of Diabefly, their digital therapeutics program to prevent, manage and reverse diabetes. It will also be used to enhance Fitterfly’s technology stack to give unique clinical insights.
Speaking about this, Dr Arbinder Singal, CEO and Co-Founder, Fitterfly said, “We want to take our clinically-proven diabetes and weight management system to the people who need it the most. This funding will help us strengthen our research, launch new verticals in the heart health space and grow our customer base by reaching out to people living with diabetes as well as the universe of doctors and organizations in the field of chronic disease management. Our corporate wellness models are pushing the envelope from ‘tick-mark-based bundling’ to an ‘outcome-based approach’.